SEC Form 5 · accession 0001209191-19-010466
Lineage Cell Therapeutics, Inc. · LCTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alfred D Kingsley
Director
Period of report
Dec 31, 2018
Accepted (ET)
Feb 14, 2019 · 8:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000876343
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, no par valueF1,F2 | Nov 1, 2018 | G | 20,000 | — | D | 5,451,555 | D | |
| Common Shares, no par value | holding | — | — | — | 1,043,346 | I | By Greenbelt Corp. | |
| Common Shares, no par value | holding | — | — | — | 375,351 | I | By Greenway Partners, LP |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1During November 2018, Mr. Kingsley gifted a total of 20,000 common shares.
- F2Does not include shares that Mr. Kingsley may acquire through the exercise of certain options.